RESUMEN
Cisplatin is used widely for treatment of a variety of cancer diseases. Recently, however, the use of cisplatin is restricted because of its adverse effects such as hepatotoxicity. There is no study with current proteomics technology to evaluate cisplatin-induced hepatotoxicity, even if some studies have reported on the hepatotoxicity. In this study, proteomic as well as genomic analyses have been used for identification of proteins and genes that respond to cisplatin treatment in rat primary hepatocytes. To investigate the hepatotoxic effects of cisplatin, rat primary hepatocytes were treated with an IC(20) concentration for 24 h. From proteomic analysis based on label-free quantitation strategy, cisplatin induced 76 up-regulated and 19 down-regulated proteins among 325 distinct proteins. In the mRNA level, genomic analysis revealed 72 up-regulated and 385 down-regulated genes in the cisplatin-treated group. Based on these two analyses, 19 pathways were commonly altered, whereas seven pathways were identified only by proteomic analysis, and 19 pathways were identified only by genomic analysis. Overall, this study explained the mechanism of cisplatin-induced hepatotoxicity with two points of view: well known pathways including drug metabolism, fatty acid metabolism, and glycolysis/TCA cycle and little known pathways including urea cycle and inflammation metabolism, for hepatotoxicity of other toxic agents. Up-regulated proteins detected by proteomic analysis in the cisplatin-treated group: FBP1 (fructose 1,6-bisphosphatase 1), FASN (fatty acid synthase), CAT (catalase), PRDX1 (peroxiredoxin-1), HSPD1 (60-kDa heat shock protein), MDH2 (malate dehydrogenase 2), and ARG1 (arginase 1), and also down-regulated proteins in the cisplatin-treated group: TPM1 (tropomyosin 1), TPM3 (tropomyosin 3), and CTSB (cathepsin B), were confirmed by Western blot analysis. In addition, up-regulated mRNAs detected by microarray analysis in the cisplatin-treated group: GSTA2, GSTT2, YC2, TXNRD1, CYP2E1, CYP2C13, CYP2D1, ALDH17, ARG1, ARG2, and IL-6, and also down-regulated mRNAs: CYP2C12, CYP26B1, TPM1, and TPM3, were confirmed by RT-PCR analysis. In case of PRDX1, FASN, and ARG1, they were further confirmed by immunofluorescence analysis. Through the integrated proteomic and genomic approaches, the present study provides the first pathway map related to cisplatin-induced hepatotoxicity, which may provide new insight into the mechanism of hepatotoxicity.
Asunto(s)
Antineoplásicos/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Cisplatino/toxicidad , Hepatocitos/efectos de los fármacos , Animales , Células Cultivadas , Perfilación de la Expresión Génica , Hepatocitos/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Proteómica , ARN Mensajero/metabolismo , RatasRESUMEN
The brain is highly vulnerable to oxidative stress, thus controlling oxidative stress is considered to be an important therapeutic target for neurodegenerative diseases. In this study, we found that two isoflavone metabolites (tectorigenin and glycitein) inhibited hydrogen peroxide-induced reactive oxygen species (ROS) generation and subsequent cell death in rat primary astrocytes. The isoflavone metabolites increased the expression of phase II antioxidant enzymes, such as hemeoxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1), and pre-treatment of cells with their specific inhibitors or small interfering RNA (siRNA) reversed the antioxidant and cytoprotective effects of isoflavones. The results suggest that the antioxidant/cytoprotective effects of isoflavone metabolites are at least because of increased HO-1 and NQO1 expression. Further mechanistic studies revealed that isoflavones increase the binding of transcription factors [nuclear factor-E2-related factor 2 (Nrf2) and c-Jun] to the antioxidant response element (ARE) on HO-1 and NQO1 promoters. Down-regulation of Nrf2 and/or c-Jun using dominant-negative mutants (DNMs) or siRNA diminished the expression of HO-1 and NQO1, suggesting that Nrf2 and c-Jun are key transcription factors modulating HO-1/NQO1 expression. Moreover, PI3 kinase and mitogen-activated protein kinase (MAPK) signaling pathways were shown to be involved in HO-1 and/or NQO1 expression by isoflavones. Our data collectively suggest that HO-1 and NQO1 play a critical role in antioxidant effects of isoflavone metabolites in rat brain astrocytes.
Asunto(s)
Antioxidantes/farmacocinética , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Hemo-Oxigenasa 1/genética , Peróxido de Hidrógeno/farmacología , Isoflavonas/farmacocinética , NAD(P)H Deshidrogenasa (Quinona)/genética , Animales , Antioxidantes/química , Astrocitos/enzimología , Línea Celular Tumoral , Hemo-Oxigenasa 1/biosíntesis , Isoflavonas/química , NAD(P)H Deshidrogenasa (Quinona)/biosíntesis , Oxidantes/farmacología , RatasRESUMEN
We determined rates of resistance to the ketolide telithromycin in 56 Enterococcus faecalis isolates and 44 Enterococcus faecium isolates collected from hospitals in Korea between 2005 and 2006. Twenty nine (51.8%) isolates of E. faecalis and 35 (79.5%) isolates of E. faecium were resistant to telithromycin (minimum inhibitory concentrations, ≥ 4 µg/mL). All of the telithromycin-resistant E. faecalis carried the erm(B) gene only. Of the telithromycin-resistant E. faecium, 29 resistant strains carried erm(B) only, the other six carried erm(A) and erm(B) together. The nucleotide sequence of the erm(B) regulatory regions from 29 E. faecalis and 29 E. faecium isolates with erm(B) only was analyzed. Five types of alterations were detected. The first and second types had point mutations that destabilize the secondary structure of erm(B) mRNA sequestering the translation initiation region of the structural gene. The third type was identical to erm(Bv1), a previously reported variant of erm(B) with different induction specificity. The fourth and fifth types had point mutations within the critical sequence for induction and a point mutation destabilizing the stem-loop of erm(B) mRNA sequestering the translation initiation region of the structural gene.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple/genética , Enterococcus faecalis/genética , Enterococcus faecium/genética , Genes Bacterianos , Cetólidos/farmacología , Secuencia de Bases , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecium/efectos de los fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Conformación de Ácido Nucleico , Mutación Puntual , Secuencias Reguladoras de Ácidos Nucleicos/efectos de los fármacos , Secuencias Reguladoras de Ácidos Nucleicos/genética , Análisis de Secuencia de ADNRESUMEN
OBJECTIVES: The in vitro pharmacodynamics of silver(I) and silver(II) complexes of a polydiguanide ligand, chlorhexidine, were assayed to examine the value of the bactericidal endpoint as an alternative means of evaluating their antibacterial activities against burn wound pathogens. METHODS: Synthesis of silver(I) chlorhexidine [Ag(I)CHX] was accomplished by in situ precipitation of the complex from a feebly acidic or neutral aqueous solution of AgNO(3) and chlorhexidine, whereas silver(II) chlorhexidine [Ag(II)CHX] was synthesized by oxidation of Ag(I), followed by complexation of the oxidized metal with chlorhexidine. Their antibacterial potencies were assessed in vitro by determining the MICs and MBCs for four Gram-positive and four Gram-negative bacteria. Time-kill assays using three different concentrations of these agents were also performed. RESULTS: The MICs of Ag(I)CHX and Ag(II)CHX were much lower than those of chlorhexidine, AgNO(3) and silver sulfadiazine. The time-kill study provided quantitative information on actual times required to reach the bactericidal endpoint using a particular concentration of the active agent. The lethality rates of Ag(I)CHX and Ag(II)CHX against the tested bacteria were 2× to 8× faster than those of chlorhexidine or AgNO(3) at a concentration equal to or 4× MIC. CONCLUSIONS: Ag(I)CHX and Ag(II)CHX showed superior antibacterial activity and faster killing kinetics compared with chlorhexidine and AgNO(3). These complexes may serve as new-generation antibacterial agents in wound care.
Asunto(s)
Antibacterianos/farmacología , Clorhexidina/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Compuestos de Plata/farmacología , Antibacterianos/síntesis química , Quemaduras/complicaciones , Clorhexidina/análogos & derivados , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Compuestos de Plata/síntesis química , Factores de Tiempo , Infección de Heridas/microbiologíaRESUMEN
Although AIMP3/p18 is normally associated with the macromolecular tRNA synthetase complex, recent reports have revealed a new role of AIMP3 in tumor suppression. In this study, we generated a transgenic mouse that overexpresses AIMP3 and characterized the associated phenotype in vivo and in vitro. Surprisingly, the AIMP3 transgenic mouse exhibited a progeroid phenotype, and the cells that overexpressed AIMP3 showed accelerated senescence and defects in nuclear morphology. We found that overexpression of AIMP3 resulted in proteasome-dependent degradation of mature lamin A, but not of lamin C, prelamin A, or progerin. The resulting imbalance in the protein levels of lamin A isoforms, namely altered stoichiometry of prelamin A and progerin to lamin A, appeared to be responsible for a phenotype that resembled progeria. An increase in the level of endogenous AIMP3 has been observed in aged human tissues and cells. The findings in this report suggest that AIMP3 is a specific regulator of mature lamin A and imply that enhanced expression of AIMP3 might be a factor driving cellular and/or organismal aging.
Asunto(s)
Regulación hacia Abajo , Lamina Tipo A/metabolismo , Factores de Elongación de Péptidos/metabolismo , Progeria/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Envejecimiento , Animales , Células Cultivadas , Femenino , Células HeLa , Humanos , Ratones , Ratones Transgénicos , Fenotipo , Complejo de la Endopetidasa Proteasomal/metabolismoRESUMEN
BACKGROUND: This study was performed to determine the extended spectrum of quinolone resistance caused by increased mutations within the target enzymes of quinolones. METHODS: The minimum inhibitory concentrations (MICs) for ciprofloxacin, sparfloxacin, trovafloxacin and DW286 were determined against 98 ciprofloxacin-resistant Staphylococcus aureus strains. Also, PCR-amplified grlA, grlB, gyrA and gyrB DNA fragments were sequenced and amino acid changes were analyzed. RESULTS: The MIC(50) values of quinolones decreased with later-generation compounds, i.e. >or=64 microg/ml for ciprofloxacin, 16 microg/ml for sparfloxacin, 2 microg/ml for trovafloxacin and 0.25 microg/ml for DW286. Combinations of amino acid changes within GrlA (Ser-80, Tyr-83 or Glu-84), GrlB (Pro-451, Pro-585 or Asp-432) and GyrA (Ser-84, Ser-85 or Glu-88) were constructed. The combination of Ser-80-->Phe within GrlA and Ser-84-->Leu within GyrA was the fundamental combination in alterations involved in ciprofloxacin resistance, and additional alterations extended quinolone resistance. CONCLUSION: A larger number of alterations within GrlA and GyrA further extended the spectrum of quinolone resistance.
Asunto(s)
Antibacterianos/farmacología , Fluoroquinolonas/farmacología , Staphylococcus aureus/efectos de los fármacos , Secuencia de Aminoácidos , Girasa de ADN/genética , ADN Bacteriano , Farmacorresistencia Bacteriana/genética , Proteínas de Escherichia coli/genética , Pruebas de Sensibilidad Microbiana , Mutación , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Staphylococcus aureus/enzimología , Staphylococcus aureus/genética , Transactivadores/genéticaAsunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/antagonistas & inhibidores , Topoisomerasa de ADN IV/antagonistas & inhibidores , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/enzimología , Inhibidores de Topoisomerasa II , Sustitución de Aminoácidos/genética , Proteínas Bacterianas/genética , Girasa de ADN/genética , Topoisomerasa de ADN IV/genética , Humanos , Pruebas de Sensibilidad Microbiana , Mutación MissenseRESUMEN
Aminoacyl-tRNA synthetases (ARSs) are highly conserved for efficient and precise translation of genetic codes. In higher eukaryotic systems, several different ARSs including glutamyl-prolyl-, isoelucyl-, leucyl-, methionyl-, glutaminyl-, lysyl-, arginyl-, and aspartyl-tRNA synthetase form a macromolecular protein complex with three nonenzymatic cofactors (AIMP1/p43, AIMP2/p38, and AIMP3/p18). Although the structure and functional implications for this complex formation are not completely understood, rapidly accumulating evidences suggest that this complex would work as a molecular hub linked to the multiple signaling pathways that involve the components of enzymes and cofactors. In this article, the roles of three nonenzymatic components of the multi-tRNA synthetase complex in the assembly of the components and in cell regulation are addressed.
Asunto(s)
Aminoacil-ARNt Sintetasas/metabolismo , Aspartato-ARNt Ligasa/metabolismo , Células/metabolismo , Proteínas/metabolismo , Aminoacil-ARNt Sintetasas/química , Aminoacil-ARNt Sintetasas/genética , Animales , Cricetinae , Eucariontes , Homeostasis , Fenómenos Fisiológicos , Aminoacil-ARN de Transferencia , Transducción de SeñalRESUMEN
To achieve more accurate and rapid detection of macrolidelincosamide- streptogramin B resistance genes, erm(A), erm(B), and erm(C), we developed a TaqMan probe-based real-time PCR (Q-PCR) method and compared it with conventional PCR (C-PCR), which is the most widely using erm gene identification method. The detection limit of Q-PCR was 5 fg of genomic DNA or 5-8 CFU of bacterial cells of Staphylococcus aureus. The utilization of Q-PCR might shorten the time to erm detection from 3-4 h to about 50 min. These data indicated that Q-PCR assay appears to be not only highly sensitive and specific, but also the most rapid diagnostic method. Therefore, the appropriate application of the Q-PCR assay will permit rapid and accurate identification of erm genes from clinical and other samples.
Asunto(s)
Proteínas Bacterianas/genética , Infección Hospitalaria/microbiología , Sondas de ADN , Bacterias Grampositivas/genética , Infecciones por Bacterias Grampositivas/microbiología , Metiltransferasas/genética , Reacción en Cadena de la Polimerasa/métodos , Antibacterianos/farmacología , Proteínas Bacterianas/análisis , Cartilla de ADN , Farmacorresistencia Bacteriana Múltiple/genética , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/aislamiento & purificación , Humanos , Lincosamidas/farmacología , Macrólidos/farmacología , Metiltransferasas/análisis , Sensibilidad y Especificidad , Estreptogramina B/farmacología , Factores de TiempoRESUMEN
Highly monodispersed nanoparticles of a trivalent silver polydiguanide complex are synthesized by oxidation of the monovalent silver, followed by stabilization of the oxidized higher-valent metal through complexation with a polydiguanide ligand in a reverse microemulsion at room temperature. The synthesized nanoparticles have excellent photostability and displayed superior antibacterial activity toward Gram-positive and Gram-negative prokaryotes of clinical interest in vitro compared to silver sulfadiazine. These nanoparticles may serve as a new generation antibacterial metallopharmaceutical in wound care.
Asunto(s)
Antibacterianos/síntesis química , Compuestos de Plata/síntesis química , Compuestos de Plata/farmacología , Estabilidad de Medicamentos , Emulsiones , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Ligandos , Nanopartículas del Metal , Nanopartículas/química , Oxidación-ReducciónRESUMEN
AIMP2 (aminoacyl-tRNA synthetase interacting multifunctional protein 2; also known as JTV-1) was first identified as p38 in a macromolecular protein complex that consisted of nine different aminoacyl-tRNA synthetases and two other auxiliary factors. AIMP2 also plays pivotal roles in the regulation of cell proliferation and death. Although AIMP2 was previously shown to augment TNFalpha-induced cell death, its working mechanism in this signal pathway was not understood. Here, we investigate the functional significance and mode of action of AIMP2 in TNFalpha signaling. TNFalpha-induced cell death was compromised in AIMP2-deficient or -suppressed cells and exogenous supplementation of AIMP2 augmented apoptotic sensitivity to TNFalpha signaling. This activity was confirmed by the AIMP2-dependent increase of IkappaB and suppression of NFkappaB. We found binding of AIMP2 to TRAF2, a key player in the TNFalpha signaling pathway. AIMP2 augmented the association of an E3 ubiquitin ligase, c-IAP1, with TRAF2, causing ubiquitin-dependent degradation of TRAF2. These findings suggest that AIMP2 can mediate the pro-apoptotic activity of TNFalpha via the downregulation of TRAF2 expression.
Asunto(s)
Aminoacil-ARNt Sintetasas/fisiología , Apoptosis , Factor 2 Asociado a Receptor de TNF/metabolismo , Factor de Necrosis Tumoral alfa/farmacología , Ubiquitina/metabolismo , Animales , Western Blotting , Células Cultivadas , Embrión de Mamíferos/citología , Embrión de Mamíferos/metabolismo , Fibroblastos/metabolismo , Citometría de Flujo , Humanos , Inmunoprecipitación , Proteínas Inhibidoras de la Apoptosis/genética , Proteínas Inhibidoras de la Apoptosis/metabolismo , Ratones , Ratones Noqueados , FN-kappa B/genética , FN-kappa B/metabolismo , Transducción de Señal , Factor 2 Asociado a Receptor de TNF/genética , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismoRESUMEN
According to an old historical text, Nihonshoki [Chinese and Korean characters: see text]), there are records of medical doctors ([Chinese and Korean characters: see text]) and herbal pharmacists ([Chinese and Korean characters: see text]) being dispatched to Japan as early as 554 A.D. ([Chinese and Korean characters: see text]). More recently, a clinic ([Chinese and Korean characters: see text]) for Japanese residents in Pusan was established in 1877. Advanced modern pharmacy from Japan began to be introduced to Korea after 1909. Based on an agreement between the Korean and Japanese governments, Korean students sent to Japan with expenses funded by the Japanese government became a systematic program after 1965. As a result, Koreans who earned Ph.D.s from Japanese universities became a majority in the faculties of Korean schools of pharmacy. However, this trend drastically shifted in the years after 1990, at which time the primary nation for earning Ph.D.s became the United States; the number of students studying in Japan has become very low recently. In this study, six ex-students who studied in Japan were interviewed and the results were analyzed. Furthermore, the past, present and future perspectives of Korean students in Japan were discussed while focusing on the system of Korean students being sent to Japan with expenses funded by the Japanese government.
Asunto(s)
Química Farmacéutica/educación , Intercambio Educacional Internacional/historia , Química Farmacéutica/historia , Historia del Siglo XX , Japón , Corea (Geográfico) , Apoyo a la Formación Profesional/historiaRESUMEN
Frequencies of spontaneous mutation from inducible resistance to constitutive resistance were determined for the four clinical isolates of erythromycin-resistant enterococci, including one isolate with ermB gene and three clinical isolates with ermA gene. The rate of ermB mutation was higher than that of ermA mutation by more than 10 fold. Sequence analysis of the regulatory regions of erm genes revealed that mutation type of ermB was just point mutation, by contraries the mutation type of ermA was either deletion or tandem duplication. These results showed distinct characteristics in mutation patterns of ermB and ermA.
Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Farmacorresistencia Bacteriana/genética , Enterococcus faecalis/genética , Enterococcus faecium/genética , Macrólidos/farmacología , Metiltransferasas/genética , Mutación , Análisis Mutacional de ADN , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/enzimología , Enterococcus faecium/efectos de los fármacos , Enterococcus faecium/enzimología , Eritromicina/farmacología , Regulación Bacteriana de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Genotipo , Josamicina/farmacología , Fenotipo , Mutación Puntual , Eliminación de SecuenciaRESUMEN
Although AIMP3/p18 is normally associated with the multi-tRNA synthetase complex via its specific interaction with methionyl-tRNA synthetase, it also works as a tumor suppressor by interacting with ATM, the upstream kinase of p53. To understand the molecular interactions of AIMP3 and the mechanisms involved, we determined the crystal structure of AIMP3 at 2.0-angstroms resolution and identified its potential sites of interaction with ATM. AIMP3 contains two distinct domains linked by a 7-amino acid (Lys57-Ser63) peptide, which contains a 3(10) helix. The 56-amino acid N-terminal domain consists of two helices into which three antiparallel beta strands are inserted, and the 111-amino acid C-terminal domain contains a bundle of five helices (Thr64-Tyr152) followed by a coiled region (Pro153-Leu169). Structural analyses revealed homologous proteins such as yeast glutamyl-tRNA synthetase, Arc1p, EF1Bgamma, and glutathione S-transferase and suggested two potential molecular binding sites. Moreover, mutations at the C-terminal putative binding site abolished the interaction between AIMP3 and ATM and the ability of AIMP3 to activate p53. Thus, this work identified the two potential molecular interaction sites of AIMP3 and determined the residues critical for its tumor-suppressive activity through the interaction with ATM.
Asunto(s)
Proteínas de Ciclo Celular/química , Proteínas de Unión al ADN/química , Factores de Elongación de Péptidos/fisiología , Proteínas Serina-Treonina Quinasas/química , Proteínas Supresoras de Tumor/química , Secuencia de Aminoácidos , Proteínas de la Ataxia Telangiectasia Mutada , Clonación Molecular , Glutatión Transferasa/metabolismo , Humanos , Modelos Biológicos , Conformación Molecular , Datos de Secuencia Molecular , Mutación , Factores de Elongación de Péptidos/química , Conformación Proteica , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Homología de Secuencia de Aminoácido , Proteína p53 Supresora de Tumor/metabolismo , Proteínas Supresoras de Tumor/fisiologíaRESUMEN
Translational attenuation has been proposed to be the mechanism by which the erm(B) gene is induced. Here, we report genetic and biochemical evidence, obtained by using erythromycin as the inducing antibiotic, that supports this hypothesis. We also show that erythromycin increases the level of the erm(B) transcript by stalling the ribosome on the leader mRNA and thereby facilitating the stabilization and processing of the mRNA. Erythromycin-induced mRNA stabilization and processing were observed with an ochre stop at codons 11 to 13 of the leader but not with an ochre stop at codon 10. This suggests that erythromycin does not stall the ribosome before codon 11 of the leader reaches the aminoacyl site. Secondary structure analyses of the erm(B) transcripts by in vitro and in vivo chemical probing techniques identified conformational changes in the transcripts that result from induction by erythromycin. These findings demonstrate that stalling of erythromycin-bound ribosomes at leader codon 11 causes the refolding of mRNA into a conformation in which the translational initiation site for the structural gene is unmasked and renders erm(B) translationally active.
Asunto(s)
Eritromicina/farmacología , Biosíntesis de Proteínas/efectos de los fármacos , ARN Mensajero/metabolismo , Codón/genética , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Estabilidad del ARN/efectos de los fármacos , ARN Mensajero/genética , Ribosomas/metabolismoRESUMEN
OBJECTIVES: We identified Staphylococcus aureus strains having blunt inhibitory zones around the clindamycin or josamycin discs proximal to the erythromycin disc filled with slight bacterial growth. This ambiguous phenotype was termed as 'macrolide-lincosamide-streptogramin B antimicrobial (MLS(B)) resistance having a foggy D-shaped inhibitory zone' (fMLS(B)), and we tried to analyse its molecular mechanisms. METHODS: Forty-one clinically isolated strains of fMLS(B) S. aureus were studied. The regulatory region of the erm(A) gene, which was found to be the only molecular mechanism of fMLS(B), was sequenced. Then, beta-galactosidase assays were performed to observe their expression patterns through the nucleotide sequential alteration. RESULTS: According to the sequencing electropherogram, a grouping was made of a homogeneous nucleotide sequence group (73.2%) and a heterogeneous nucleotide sequence group (26.8%). The former group was composed of a 25 bp tandem duplication type and a 25 bp tandem triplication type. Their beta-galactosidase activity was similar to that of constitutive MLS(B) resistance due to its high basal level. Nevertheless, the predicted mRNA secondary structure of the regulatory region maintains the stem-loops of inducible wild-type erm(A), and thereby its inducible character might be expected in vivo. Strains in the latter group were proven to have two different erm(A) genes, and then dual effect of expression was observed. CONCLUSIONS: The ambiguous phenotype of fMLS(B) is due to its possessing the dual character of inducible and constitutive expression of erm(A). The dual character is due to having one erm(A) gene of dual character or coexistence of two characterized erm(A) genes simultaneously.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Macrólidos/farmacología , Staphylococcus aureus/efectos de los fármacos , Estreptogramina B/farmacología , Combinación de Medicamentos , Farmacorresistencia Bacteriana Múltiple/genética , Humanos , Lincosamidas , Pruebas de Sensibilidad Microbiana/métodos , Staphylococcus aureus/crecimiento & desarrollo , Staphylococcus aureus/aislamiento & purificaciónRESUMEN
The antibacterial activities of clindamycin, synercid, telithromycin, linezolid and mupirocin were evaluated against erythromycin-resistant Gram-positive coccal clinical isolates collected in Korean hospitals. In Staphylococcus aureus, synercid, linezolid and mupirocin were the most active agents. Against coagulase-negative staphylococci (CNS), synercid, linezolid and mupirocin were also active. Telithromycin and synercid resistance was common against enterococci, only linezolid and mupirocin were active. The reason of low activity of telithromycin against staphylococci and enterococci is because most of the isolates were constitutively resistant to erythromycin. Synercid, telithromycin, linezolid and mupirocin were active against streptococci.
Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Eritromicina/farmacología , Cocos Grampositivos/efectos de los fármacos , Acetamidas/farmacología , Clindamicina/farmacología , Infecciones por Bacterias Grampositivas/microbiología , Cocos Grampositivos/aislamiento & purificación , Humanos , Cetólidos/farmacología , Corea (Geográfico) , Linezolid , Pruebas de Sensibilidad Microbiana , Mupirocina/farmacología , Oxazolidinonas/farmacología , Virginiamicina/farmacologíaRESUMEN
The quinolone analog SQ-4004 has been identified as a potentially excellent anti-ischemic agent, which exhibited highly potent efficacy in reducing infarct volume size in vivo rat MCAO model (32.1% at 0.01mg/kg) and potent cardioprotective effect at myocardial infarction in vivo model (26.6% at 0.01mg/kg) while it exhibited highly reduced anti-bacterial activity. The mechanistic study revealed that the anti-ischemic activity might exert via an anti-apoptotic pathway, which implies its therapeutic uses against the ischemic cell injuries including ischemic stroke and ischemic heart disease.
Asunto(s)
Isquemia Encefálica/patología , Quinolinas/química , Quinolinas/farmacología , Animales , Antibacterianos/química , Antibacterianos/farmacología , Isquemia Encefálica/tratamiento farmacológico , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Humanos , Modelos Biológicos , Estructura Molecular , Infarto del Miocardio/tratamiento farmacológico , Infarto del Miocardio/patología , Quinolinas/síntesis química , Quinolinas/uso terapéutico , Ratas , Relación Estructura-ActividadRESUMEN
PURPOSE: To compare the bacterial susceptibility and corneal epithelial toxicity of levofloxacin and moxifloxacin in the human corneal epithelial cells (HCECs). METHODS: We used 2 types of strains, ie, American Type Culture Collection strains and resistant strains. The former included Staphylococcus aureus, coagulase-negative staphylococci, Pseudomonas aeruginosa, and Serratia marcescens, The latter were methicillin-resistant Staphylococcus aureus; methicillin-resistant, coagulase-negative Staphylococcus sp.; and ciprofloxacin-resistant P. aeruginosa. The HCECs were incubated with each bacterial population for 1 hour and exposed to both antibiotics for 1 hour. The colony-forming units of viable bacteria per well were expressed as base 10 logarithms. To determine corneal epithelial toxicity, we exposed the HCECs to each antibiotic agent, and the viable epithelial cells were quantified by the MTT assay. We also observed the wound healing rate of injured HCECs cultured in each antibiotic agent for 24 hours. RESULTS: In bacterial susceptibility testing of antibiotics, levofloxacin was less effective for Serratia marcescens than moxifloxacin (P < 0.05). However, both moxifloxacin and levofloxacin showed the same efficacy against Gram-positive bacteria, P. aeruginosa, and resistant strains (P > 0.05). Moxifloxacin showed a higher toxicity than levofloxacin when the HCECs were exposed to the respective antibiotics for 2 and 24 hours (P < 0.05). The moxifloxacin inhibited the effect of wound healing in HCEC injury, but levofloxacin did not (P < 0.05). CONCLUSIONS: There was no significant difference in antibiotic effects between moxifloxacin and levofloxacin on most bacterial strains, except for Serratia marcescens. On the other hand, levofloxacin seemed to be safer than moxifloxacin in HCECs.
Asunto(s)
Antibacterianos/toxicidad , Compuestos Aza/toxicidad , Epitelio Corneal/efectos de los fármacos , Levofloxacino , Ofloxacino/toxicidad , Pseudomonas aeruginosa/efectos de los fármacos , Quinolinas/toxicidad , Serratia marcescens/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Técnicas Bacteriológicas , Recuento de Células , Supervivencia Celular , Células Cultivadas , Ciprofloxacina/farmacología , Recuento de Colonia Microbiana , Farmacorresistencia Bacteriana , Epitelio Corneal/microbiología , Fluoroquinolonas , Humanos , Resistencia a la Meticilina , Pruebas de Sensibilidad Microbiana , MoxifloxacinoRESUMEN
The macromolecular tRNA synthetase complex consists of nine different enzymes and three non-enzymatic factors. This complex was recently shown to be a novel signalosome, since many of its components are involved in signaling pathways in addition to their catalytic roles in protein synthesis. The structural organization and dynamic relationships of the components of the complex are not well understood. Here we performed a systematic depletion analysis to determine the effects of structural intimacy and the turnover of the components. The results showed that the stability of some components depended on their neighbors. Lysyl-tRNA synthetase was most independent of other components for its stability whereas it was most required for the stability of other components. Arginyl- and methionyl-tRNA synthetases had the opposite characteristics. Thus, the systematic depletion of the components revealed the functional reason for the complex formation and the assembly pattern of these multi-functional enzymes and their associated factors.